The 2024 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day meeting featuring interactive and case-based educational sessions that cover new multidisciplinary therapies, imaging, immunotherapy, treatment guidelines, supportive care and understanding disparities in head and neck cancer. A major focus is placed on the multidisciplinary nature of disease management and the incorporation of all treatment modalities to achieve best outcomes. Oral abstract and poster sessions will highlight cutting-edge science and evidence-based practice. Attendees will be able to examine multidisciplinary approaches for treating head and neck cancer, as well as novel therapies that show promise in improving outcomes.
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.
Upon completion of this activity, participants should be able to do the following:
Course opens: 03/11/2024